Delivery Order SPE2DE21D7020-SPE2D624F6C6C

Award Date 5/21/24
Potential Completion Date 5/29/24
Potential Value $37K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Marlborough, MA 01752, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a leading manufacturer of medical devices, for the delivery of agent drug-coated balloons. The award has a ceiling value of $18,525.00 and an ultimate completion date of November 12, 2024. The contract is a fixed-price agreement with economic price adjustment and is not set aside for any specific business type. This delivery order is likely part of a larger indefinite delivery/indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Boston Scientific Corp, a global medical technology company based in Marlborough, Massachusetts. The contract is for the delivery of AGENT Drug Coated Balloons, a specialized medical device. The contract has a ceiling value of $10,399.00 and a period of performance through April 8, 2025. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type. This award is not associated with a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Boston Scientific Corp, a global medical technology company based in Marlborough, Massachusetts. The contract, valued at $6,175.00, is for the delivery of agent drug-coated balloons. It is a fixed-price with economic price adjustment contract type, with a period of performance through January 22, 2025. The contract has no set-aside designation. Boston Scientific Corp is the prime contractor for this award, which supports...
This is a fixed-price delivery order awarded by the Medical Supply Chain, a defense agency within the Department of Defense, to Boston Scientific Corp. The contract is for the supply of a drug-coated balloon medical device, with a ceiling value of $37,050 and a period of performance ending on May 29, 2024. Boston Scientific, a leading manufacturer of medical devices, is the prime contractor for this award, which is not set aside. The award appears to be part of a larger indefinite...
This federal contract award was issued by the Defense Health Agency (DHA), a component of the Department of Defense, to Boston Scientific Corporation, a leading manufacturer of medical devices. The $37,050 fixed-price delivery order is for the provision of an "AGENT DRUG COATED BALLOON" product. This award does not utilize a set-aside designation. The contract has an ultimate completion date of May 29, 2024. Boston Scientific is the prime contractor for this award and has been issued...
This is a $37,050 fixed-price with economic price adjustment delivery order contract awarded to Boston Scientific Corp by the Defense Logistics Agency (DLA) for the supply of drug-coated balloons, which are a type of medical device used in cardiovascular procedures. The contract has a performance period that extends to May 2024. Boston Scientific, a leading manufacturer of medical technologies, has been providing a wide range of innovative medical devices and services to federal healthcare...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp, valued at $37,050.00, for the delivery of 4564674815 Agent Drug Coated Balloon medical devices. The contract has a fixed price with economic price adjustment pricing type and a completion date of May 29, 2024. Boston Scientific is a leading manufacturer of medical devices, including implantable cardioverter defibrillators, pacemakers, and other cardiovascular, endoscopic, and neurostimulation...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation for an "AGENT DRUG COATED BALLOON" medical device. The order has a ceiling value of $6,175 and a completion date of September 16, 2024. This appears to be a task order issued under a larger indefinite delivery/indefinite quantity (IDIQ) contract, as the award references a base contract number. Boston Scientific is a leading manufacturer of medical devices, including specialized...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts. The contract, valued at $22,382.37, is for the delivery of "AGENT DRUG COATED BALLOON" medical devices, with a performance period through March 10, 2025. The contract has a fixed-price with economic price adjustment pricing type and does not utilize any set-aside designations. Boston...
This is a federal contract award with ID SPE2DE21D7020|SPE2D625F41MH, awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp, a for-profit manufacturer of medical devices and solutions. The contract is for the delivery of "AGENT DRUG COATED BALLOON", a specialized medical product, with a ceiling value of $83,788.65 and a completion date of January 31, 2025. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type. There is no...
  • SPE2DE21D7020
    Indefinite Delivery Contract
  • SPE2DE21D7020-SPE2D624F6C6C
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Boston Scientific Corp, a leading manufacturer of medical devices, for the delivery of agent drug coated balloons. The contract has a ceiling value of $37,050.00 and is a delivery order under a larger indefinite delivery/indefinite quantity (IDIQ) contract. The contract is a fixed price with economic price adjustment type and has an ultimate completion date of May 29, 2024. The contract does not have a set-aside designation. Boston Scientific, as the prime contractor, will be responsible for providing the requested medical devices to support federal healthcare agencies, particularly the Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). This award leverages Boston Scientific's expertise in developing and manufacturing specialized medical technologies, including implantable devices, catheters, and surgical implants, which are utilized by the federal government to deliver advanced medical care to patients.

Generated 8/20/24, 9:24 AM